SCHEMBL342453

SCHEMBL342453

CCCCCCCCC=CCCCCCCCCOCC(C)(C)C=O

nearest known ligand 0.51

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.48
TRPV1 Q8NER1 1/20 0.48
LPAR1 Q92633 2/20 0.42
LPAR2 Q9HBW0 2/20 0.42
LPAR3 Q9UBY5 2/20 0.42
CES1 P23141 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL342451 1.00 FAAH (0.48) FAAHTRPV1LPAR1LPAR2LPAR3
SCHEMBL341903 0.91 CES1 (0.47) LPAR1LPAR2LPAR3CES1
SCHEMBL2925106 0.91 CES1 (0.47) LPAR1LPAR2LPAR3CES1
SCHEMBL11220391 0.91 CES1 (0.47) LPAR1LPAR2LPAR3CES1
SCHEMBL342032 0.91 CES1 (0.47) LPAR1LPAR2LPAR3CES1
SCHEMBL216493 0.89 CES1 (0.44) LPAR1LPAR3CES1
SCHEMBL2846235 0.84 TSHR (0.38) CES1
SCHEMBL17366573 0.82 LPAR1 (0.47) FAAHTRPV1LPAR1LPAR2LPAR3
SCHEMBL25762061 0.82 LPAR1 (0.47) FAAHTRPV1LPAR1LPAR2LPAR3
SCHEMBL17205377 0.79 LPAR1 (0.45) FAAHTRPV1LPAR1LPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283550-B1 CATALYST CONTAINING AMIDINE GROUPS SIKA TECH AG (CH) 2020-12-16 EP disclosed
EP-3294803-B1 GUANIDINE GROUP CONTAINING CATALYST SIKA TECH AG (CH) 2020-12-09 EP disclosed
US-10414875-B2 Catalyst containing guanidine groups SIKA TECHNOLOGY AG (CH) 2019-09-17 US disclosed
US-10392480-B2 Catalyst containing amidine groups SIKA TECHNOLOGY AG (CH) 2019-08-27 US disclosed
US-20180171082-A1 CATALYST CONTAINING AMIDINE GROUPS SIKA TECHNOLOGY AG (CH) 2018-06-21 US disclosed
US-20180148545-A1 CATALYST CONTAINING GUANIDINE GROUPS SIKA TECHNOLOGY AG (CH) 2018-05-31 US disclosed
EP-3294803-A1 CATALYST CONTAINING GUANIDINE GROUPS Sika Technology AG (CH) 2018-03-21 EP disclosed
EP-3283550-A1 AMIDINE-GROUP CONTAINING CATALYST Sika Technology AG (CH) 2018-02-21 EP disclosed
WO-2016180840-A1 CATALYST CONTAINING GUANIDINE GROUPS SIKA TECHNOLOGY AG (CH) 2016-11-17 WO disclosed
WO-2016166336-A1 AMIDINE-GROUP CONTAINING CATALYST SIKA TECHNOLOGY AG (CH) 2016-10-20 WO disclosed
US-8759455-B2 Two-stage curable composition containing a surface-deactivated polyisocyanate SIKA TECHNOLOGY AG (CH) 2014-06-24 US disclosed
US-20120045652-A1 COMPOSITION CONTAINING A SURFACE-DEACTIVATED POLYISOCYANATE AND CURING IN TWO STAGES SIKA TECHNOLOGY AG (CH) 2012-02-23 US disclosed
EP-2414421-A1 MOISTURE-REACTIVE POLYURETHANE COMPOSITION WITH ACCELERATED CURING ACHIEVED BY THE ACTION OF HEAT Sika Technology AG (CH) 2012-02-08 EP disclosed
US-20120012251-A1 HOT CURING OR HEAT-ACTIVATED COMPOSITION CONTAINING A SURFACE-DEACTIVATED POLYISOCYANATE SIKA TECHNOLOGY AG (CH) 2012-01-19 US disclosed
EP-2236533-B1 Heat curing or heat activatable composition comprising a surface deactivated polyisocyanate SIKA TECHNOLOGY AG (CH) 2011-11-09 EP disclosed
WO-2010112536-A1 HOT CURING OR HEAT-ACTIVATED COMPOSITION CONTAINING A SURFACE-DEACTIVATED POLYISOCYANATE SIKA TECHNOLOGY AG (CH) 2010-10-07 WO disclosed
WO-2010112535-A1 MOISTURE-REACTIVE POLYURETHANE COMPOSITION WITH ACCELERATED CURING ACHIEVED BY THE ACTION OF HEAT SIKA TECHNOLOGY AG (CH) 2010-10-07 WO disclosed
EP-2236535-A1 Humidity curing polyurethane composition being accelerated by influence of heat Sika Technology AG (CH) 2010-10-06 EP disclosed
EP-2236533-A1 Heat curing or heat activatable composition comprising a surface deactivated polyisocyanate Sika Technology AG (CH) 2010-10-06 EP disclosed
EP-2236534-A1 Composition curable in two stages comprising a surface deactivated polyisocyanate Sika Technology AG (CH) 2010-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414875-B2 Catalyst containing guanidine groups GMPS, GMNN, RNMT FAAH 3635/4885TRPV1 4177/4885LPAR1 4468/4885
US-20180148545-A1 CATALYST CONTAINING GUANIDINE GROUPS GMPS, RNMT, GMNN FAAH 3704/4885TRPV1 4642/4885LPAR1 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.